The only trial FDA staff were able to find about the effectiveness of using BPC-157 to treat ulcerative colitis was a meeting abstract reporting on the results of a study using 46 people in which the peptide was given as an enema, not as an injection
thus, clinical application awaits further verification of safety and efficacy, and they are not recommended for routine clinical use at present but are considered as exploratory research directions
Treatment involves dose escalation over several weeks to reach the maintenance dose of 2.4 mg
Does BPC-157 Support Muscle and Joint Health
And so my message and what I'm trying to work for is so much bigger than peptides
The therapeutic effects of Clostridium and their metabolites (e.g., SCFAs, butyrate, PCS, and vitamin K2) are mediated through a synergistic network of mechanisms, with precise correction of immune dysregulation standing as the most pivotal value